Overview
- 40 inspections across 38 sites are on record.
- 54 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-23.
At a glance
Inspections
40
Sites
38
Observations
54
Career since
Apr 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| TriRx Segre | 23 Apr 2026 | Animal Drugs & Feeds | On file |
| LEK Pharmaceuticals d.d. | 10 Apr 2026 | Human Drugs | |
| NEOLPHARMA, INC. | 10 Mar 2026 | Human Drugs | On file |
| Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company | 13 Feb 2026 | Human Drugs | On file |
| Gland Chemicals Private Limited | 27 Nov 2025 | Human Drugs | On file |
Sites inspected
TriRx SegreSegre-En-Anjou Bleu, France1 insp.
LEK Pharmaceuticals d.d.Lendava, Slovenia1 insp.
NEOLPHARMA, INC.Caguas, United States1 insp.
Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyManati, United States1 insp.
Gland Chemicals Private LimitedChennai, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Alan A Rivera9 shared
Marian E Ramirez7 shared
Jose E Melendez4 shared
Ariel Cruz Figueroa4 shared
Jose M Cayuela3 shared
Yoriann M Cabrera Bartolomei2 shared
Andrew Le2 shared
Damaris Y Hernandez2 shared
Eileen A Liu2 shared
Jose F Velez2 shared
Full investigator report
Get the verbatim findings behind Angelica M Hernandez's 54 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site